Digital app for monitoring speech and health in neurodegenerative conditions
Official title: Digital App for Speech & Health Monitoring in Neurodegenerative Disorders
Run by University of Edinburgh · NCT06450418 · Data updated 2026-11-12
This study is testing a digital app that records and analyzes speech to see if it can help monitor and detect neurodegenerative conditions like dementia and Parkinson's disease in both patients and healthy volunteers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University of Edinburgh Academic / other |
| Locations | 1 site (Edinburgh) |
| Status | Recruiting |
| Started | July 12, 2024 |
| Main results expected | January 30, 2029 |
| Study ends | June 2029 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT06450418 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with dementia, motor neuron disease, multiple sclerosis, or Parkinson's disease, as well as healthy volunteers without neurological conditions.
✕Probably not a fit
Patients under 16 years old or those with significant visual or hearing impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project aims to utilize a digital platform to record and analyze speech from individuals with neurodegenerative disorders such as dementia, motor neuron disease, multiple sclerosis, and Parkinson's disease, as well as healthy controls. By collecting acoustic speech data, the study seeks to develop algorithms for early detection, monitoring, and stratification of these conditions. Participants will include diagnosed individuals and healthy volunteers, allowing for comparative analysis. The findings could enhance diagnostic and monitoring capabilities for these disorders.
Why it matters
Potential benefit: If successful, this approach could lead to improved early detection and monitoring of neurodegenerative conditions, enhancing patient care.
How similar studies have gone: Other studies utilizing digital technologies for speech analysis in neurodegenerative conditions have shown promise, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria - Any one of the following: * A person with a diagnosis of Motor Neuron Disease, Dementia, Multiple Sclerosis, or Parkinson's Disease. * A relative or carer of the above who does not report to have a neurological condition. * A healthy volunteer who does not report to have a neurological condition. Exclusion Criteria: * Age \<16 years * Significant and uncorrected visual or hearing impairment (precluding use of the App). * Lack capacity to consent to project due to cognitive impairment (precluding understanding of the study and use of the App).
Where it's running
-
NHS Lothian
Edinburgh, United Kingdom Recruiting
Study contacts
- Principal investigator: Suvankar Pal, Prof — University of Edinburgh
- Study coordinator: Christine R Weaver, MSc
- Email: cweaver@ed.ac.uk
- Phone: 01314659512
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Motor learning with physical activity and advanced devices in healthy people and movement disorders
This study tests whether combining traditional physical activity with advanced devices and immersive therapy helps improve motor skills and functional recovery in healthy individuals and people with movement disorders.
-
Biobank for studying ALS and Alzheimer's diseases
This study is collecting blood, skin samples, and health information from people to see how genetics might help us understand and find treatments for ALS and Alzheimer's disease.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
OCT in Neurological Practice: Use of Retinal Layers to Help Diagnose and Follow Neurological Diseases
This study tests whether optical coherence tomography (OCT) of the retina can help in diagnosing and tracking multiple sclerosis, Alzheimer's, Parkinson's, migraines, and other headaches compared with healthy people.
-
Hyperspectral retinal imaging to detect Alzheimer’s and other neurodegenerative changes
This project will test whether a special retinal camera that scans many wavelengths of light can detect signs of Alzheimer’s and other neurodegenerative diseases in people with dementia or at risk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.